Thursday, September 22, 2016

Oncogene - Table of Contents alert Volume 35 Issue 38

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
The Return of the ChIP Kit

With Diagenode's ChIP Kit Customizer, buy only the kit-quality reagents that you want.
  • Buy only what you need! Select from individual components or full kits
  • Validated, ChIP-grade reagents including buffers, beads, controls, antibodies, and more!
Learn more.

TABLE OF CONTENTS

Volume 35, Issue 38 (September 2016)

In this issue
Review
Original Articles
Short Communication
Corrigenda

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.

Explore the benefits of submitting your next research article.

Review

Top

Arginine dependence of tumor cells: targeting a chink in cancer’s armor

M D Patil, J Bhaumik, S Babykutty, U C Banerjee and D Fukumura

Oncogene 2016 35: 4957-4972; advance online publication, April 25, 2016; 10.1038/onc.2016.37

Abstract | Full Text

Original Articles

Top

Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function

P German, S Bai, X-D Liu, M Sun, L Zhou, S Kalra, X Zhang, R Minelli, K L Scott, G B Mills, E Jonasch and Z Ding

Oncogene 2016 35: 4973-4980; advance online publication, March 14, 2016; 10.1038/onc.2016.40

Abstract | Full Text

The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2

I Roth, H Campbell, C Rubio, C Vennin, M Wilson, A Wiles, G Williams, A Woolley, P Timpson, M V Berridge, N Fleming, M Baird and A W Braithwaite

Oncogene 2016 35: 4981-4989; advance online publication, March 21, 2016; 10.1038/onc.2016.45

Abstract | Full Text

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer OPEN

Q Zhou, A D Abraham, L Li, A Babalmorad, S Bagby, J J Arcaroli, R J Hansen, F A Valeriote, D L Gustafson, J Schaack, W A Messersmith and D V LaBarbera

Oncogene 2016 35: 4990-4999; advance online publication, March 7, 2016; 10.1038/onc.2016.29

Abstract | Full Text

RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma OPEN

T Sakurai, K Isogaya, S Sakai, M Morikawa, Y Morishita, S Ehata, K Miyazono and D Koinuma

Oncogene 2016 35: 5000-5009; advance online publication, February 29, 2016; 10.1038/onc.2016.35

Abstract | Full Text

Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer

L Zhang, T Ma, J Brozick, K Babalola, R Budiu, G Tseng and A M Vlad

Oncogene 2016 35: 5010-5020; advance online publication, March 14, 2016; 10.1038/onc.2016.53

Abstract | Full Text

The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis

K B Jones, J J Barrott, M Xie, M Haldar, H Jin, J-F Zhu, M J Monument, T L Mosbruger, E M Langer, R L Randall, R K Wilson, B R Cairns, L Ding and M R Capecchi

Oncogene 2016 35: 5021-5032; advance online publication, March 7, 2016; 10.1038/onc.2016.38

Abstract | Full Text

The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action

A Griveau, G Devailly, L Eberst, N Navaratnam, B Le Calvé, M Ferrand, P Faull, A Augert, R Dante, J M Vanacker, D Vindrieux and D Bernard

Oncogene 2016 35: 5033-5042; advance online publication, April 4, 2016; 10.1038/onc.2016.43

Abstract | Full Text

The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer

X Mao, C Gauche, M W H Coughtrie, C Bui, S Gulberti, F Merhi-Soussi, N Ramalanjaona, I Bertin-Jung, A Diot, D Dumas, N De Freitas Caires, A M Thompson, J-C Bourdon, M Ouzzine and S Fournel-Gigleux

Oncogene 2016 35: 5043-5055; advance online publication, April 4, 2016; 10.1038/onc.2016.44

Abstract | Full Text

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation

P Zhang, S Feng, G Liu, H Wang, A Fu, H Zhu, Q Ren, B Wang, X Xu, H Bai and C Dong

Oncogene 2016 35: 5056-5069; advance online publication, April 4, 2016; 10.1038/onc.2016.67

Abstract | Full Text

Short Communication

Top

Hypoxia and MITF regulate KIT oncogenic properties in melanocytes

F Laugier, J Delyon, J André, A Bensussan and N Dumaz

Oncogene 2016 35: 5070-5077; advance online publication, March 14, 2016; 10.1038/onc.2016.39

Abstract | Full Text

Corrigenda

Top

miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma

X Zhou, C Z Zhang, S-X Lu, G G Chen, L-Z Li, L-L Liu, C Yi, J Fu, W Hu, J-M Wen and J-P Yun

Oncogene 2016 35: 5078; advance online publication, August 8, 2016; 10.1038/onc.2016.61

Full Text

Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing

K-T Lin, Y-J Shann, G-Y Chau, C-N Hsu and C-YF Huang

Oncogene 2016 35: 5078; advance online publication, August 1, 2016; 10.1038/onc.2016.62

Full Text

Advertisement
Have you checked out the Oncogene top 10?

We have a continuously updated list of articles that highlight what has been downloaded by our website users over the past 7 days. Take a look as you may have missed out on something that could help with your research! 

Click here to view the top 10
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: